Global Bone Growth Stimulator Market to grow at CAGR of 5.4% by 2022 according to new research report

[153 Pages Report] The global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% .

The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.

Don’t miss out on business opportunities in Bone Growth Stimulator Market.

Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

Market Drivers:

• Growing patient preference for noninvasive and minimally invasive surgical treatments
• Increasing target patient population
• Procedural benefits offered by bone stimulation devices in bone fracture treatment

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=82341383

The Major Objectives of the study:

• To define, describe, and forecast the global Bone Growth Stimulator Market on the basis of product, application, and end user
• To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To provide market size for various segments of the Bone Growth Stimulator Market with respect to four main geographies, namely, North America (U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and Rest of the World

Browse and in-depth TOC on “Bone Growth Stimulator Market”

66 — Tables

67 — Figures

153 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/bone-growth-stimulator-market-82341383.html

Major Market Developments:

• In 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.
• In 2016, Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America is expected to dominate the market in 2016. Asia is expected to grow at a highest CAGR during the forecast period. Factors such as large population base, improving healthcare infrastructure and the rising prevalence of obesity and spinal disorders are key factors driving market growth in the Asia-Pacific region.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=82341383

Orthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the Bone Growth Stimulator Market.